Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
sector : N::A entities : Amgen inc. save search
Alvotech Reports Financial Results for Full Year 2023 and Provides a Business Update
Published: 2024-03-20 (Crawled : 20:00) - globenewswire.com
ALVO | $12.9 0.78% 0.78% 90K
|
n/a
|
| O: -1.58%
H: 1.87%
C: 0.53%
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: -0.03%
H: 0.0%
C: 0.0%
ABBV | $164.66 0.25% -0.15% 4.5M
|
Health Technology
|
| O: -0.89%
H: 0.0%
C: 0.0%
KMDA | $5.075 -0.1% -0.1% 6.5K
|
Health Technology
|
| O: 0.68%
H: 0.0%
C: -1.86%
AMGN | $262.77 -0.49% -0.49% 2M
|
Health Technology
|
| O: 0.58%
H: 1.2%
C: 0.84%
business year update financial results
AMGEN PRESENTS NEW RESEARCH ON OTEZLA® (APREMILAST) AT AAD 2024
Published: 2024-03-09 (Crawled : 20:20) - prnewswire.com
BEIGF | $14.29 -9.87% 2.1K
|
n/a
| Email alert
Add to watchlist
CCXI | $51.99 -0.04%
|
Health Technology
| Email alert
Add to watchlist
BGNE S | $131.94 0.06% 0.06% 130K
|
Health Technology
| Email alert
Add to watchlist
AMGN | $262.77 -0.49% -0.49% 2M
|
Health Technology
| Email alert
Add to watchlist
otezla research
AMGEN ANNOUNCES 2024 SECOND QUARTER DIVIDEND
Published: 2024-03-06 (Crawled : 21:00) - prnewswire.com
BGNE S | $131.94 0.06% 0.06% 130K
|
Health Technology
|
| O: -0.93%
H: 3.2%
C: 2.66%
AMGN | $262.77 -0.49% -0.49% 2M
|
Health Technology
|
| O: -0.1%
H: 0.18%
C: -1.25%
AMGEN OPENS STATE-OF-THE-ART BIOMANUFACTURING SITE IN CENTRAL OHIO
Published: 2024-02-26 (Crawled : 14:00) - prnewswire.com
BGNE S | $131.94 0.06% 0.06% 130K
|
Health Technology
|
| O: 2.6%
H: 1.87%
C: 0.7%
AMGN | $262.77 -0.49% -0.49% 2M
|
Health Technology
|
| O: -0.31%
H: 0.55%
C: -0.66%
Zymeworks Announces Appointment of Dr. Alessandra Cesano to its Board of Directors
Published: 2024-02-08 (Crawled : 11:00) - globenewswire.com
ZYME | $8.68 -1.92% -1.96% 730K
|
Health Technology
|
| O: 0.26%
H: 2.42%
C: 0.97%
NSTG | News | $0.1053 -37.43% -0.19% 0
|
Health Technology
|
| O: -31.6%
H: 410.14%
C: 110.51%
BIIB | $190.55 -0.84% -0.84% 1.5M
|
Health Technology
|
| O: -0.27%
H: 0.27%
C: 0.17%
BGNE S | $131.94 0.06% 0.06% 130K
|
Health Technology
|
| O: -1.87%
H: 0.61%
C: -1.46%
AMGN | $262.77 -0.49% -0.49% 2M
|
Health Technology
|
| O: 0.38%
H: 0.34%
C: -0.72%
Generic Drugs Market to grow by USD 176.25 billion from 2022 to 2027, North America is estimated to contribute 37% to the growth - Technavio
Published: 2024-02-08 (Crawled : 05:00) - prnewswire.com
ENDPQ | $0.0006 -50.0% 620K
|
n/a
|
| O: -14.29%
H: 16.67%
C: 0.0%
GLAXF | $20.2 -14.18% 510
|
Health Technology
|
| O: 0.82%
H: 0.0%
C: 0.0%
SNYNF | News | $92.7 -2.18% 1.4K
|
Health Technology
|
| O: -1.64%
H: 0.0%
C: 0.0%
VTRS | $11.11 0.09% 0.09% 3.5M
|
Health Technology
|
| O: -0.34%
H: 0.0%
C: -1.2%
NVS | News | $92.57 -0.55% 0.0% 910K
|
Health Technology
|
| O: -1.57%
H: 0.26%
C: -0.47%
GSK | $39.27 -0.83% 0.01% 2.2M
|
Health Technology
|
| O: -0.48%
H: 0.16%
C: 0.0%
BAX | News | $39.65 0.33% 0.0% 2.3M
|
Health Technology
|
| O: -0.96%
H: 5.91%
C: 3.74%
ABT | News | $105.27 -0.6% -0.15% 7.3M
|
Health Technology
|
| O: -1.41%
H: 0.0%
C: 0.0%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: -2.25%
H: 0.0%
C: 0.0%
AMGN | $262.77 -0.49% -0.49% 2M
|
Health Technology
|
| O: 0.38%
H: 0.34%
C: -0.72%
america growth market
AMGEN REPORTS FOURTH QUARTER AND FULL YEAR 2023 FINANCIAL RESULTS
Published: 2024-02-06 (Crawled : 21:00) - prnewswire.com
BMY | $48.3 0.96% -0.1% 11M
|
Health Technology
|
| O: -0.14%
H: 0.35%
C: -1.12%
XNCR | $18.98 -0.47% -0.47% 470K
|
Health Technology
|
| O: -0.05%
H: 0.0%
C: -2.09%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: 1.33%
H: 0.0%
C: 0.0%
BGNE S | $131.94 0.06% 0.06% 130K
|
Health Technology
|
| O: -3.53%
H: 1.53%
C: -0.27%
AMGN | $262.77 -0.49% -0.49% 2M
|
Health Technology
|
| O: -0.18%
H: 0.0%
C: -6.22%
year financial results
Renal Anemia Therapeutics Market to Record Growth of USD 2.08 billion from 2023 to 2028, Akebia Therapeutics Inc and Amgen Inc to emerge as Some of the Key Companies - Technavio
Published: 2024-01-29 (Crawled : 00:00) - prnewswire.com
CMXHF | $172.54 -19.21% 50
|
n/a
|
| O: -1.84%
H: 0.52%
C: 0.52%
CSLLY | $87.96 3.3% 45K
|
n/a
|
| O: -0.25%
H: 1.0%
C: 0.98%
ALPMF | News | $9.594 43.47% 2.2K
|
Health Technology
|
| O: 1.76%
H: 0.0%
C: 0.0%
GLAXF | $20.2 -14.18% 510
|
Health Technology
|
| O: 2.93%
H: 0.0%
C: -1.15%
AZNCF | $140.15 -4.19% 560
|
Health Technology
|
| O: 3.1%
H: 0.0%
C: -3.91%
ALPMY | News | $9.46 -1.11% 500K
|
Manufacturing
|
| O: -3.53%
H: 3.49%
C: 3.4%
TVTX | $5.805 -3.09% -3.19% 970K
|
Health Technology
|
| O: -1.39%
H: 0.16%
C: -1.96%
GSK | $39.27 -0.83% 0.01% 2.2M
|
Health Technology
|
| O: 0.26%
H: 0.13%
C: -0.18%
AZN | $68.36 -0.25% -0.25% 4M
|
Health Technology
|
| O: 0.24%
H: 0.01%
C: -0.22%
AMGN | $262.77 -0.49% -0.49% 2M
|
Health Technology
|
| O: -0.29%
H: 0.76%
C: 0.67%
companies renal anemia key therapeutics growth market
Alvotech Announces Positive Top-Line Results from a Pharmacokinetic Study for AVT03, a Proposed Biosimilar for Prolia® and Xgeva®
Published: 2024-01-29 (Crawled : 09:00) - globenewswire.com
ALVO | $12.9 0.78% 0.78% 90K
|
n/a
|
| O: 2.39%
H: 4.67%
C: 1.67%
KMDA | $5.075 -0.1% -0.1% 6.5K
|
Health Technology
|
| O: -1.05%
H: 0.41%
C: -0.35%
AMGN | $262.77 -0.49% -0.49% 2M
|
Health Technology
|
| O: -0.11%
H: 0.7%
C: 0.65%
avt03 prolia biosimilar positive results study
SpringWorks Therapeutics Highlights 2023 Accomplishments and Anticipated Milestones for 2024 at the 42nd Annual J.P. Morgan Healthcare Conference
Published: 2024-01-08 (Crawled : 12:00) - globenewswire.com
SWTX | $42.48 -3.7% -3.84% 810K
|
Health Technology
|
| O: -1.58%
H: 11.22%
C: 11.16%
BGNE S | $131.94 0.06% 0.06% 130K
|
Health Technology
|
| O: 0.36%
H: 3.65%
C: 3.35%
AMGN | $262.77 -0.49% -0.49% 2M
|
Health Technology
|
| O: -0.5%
H: 3.18%
C: 3.12%
conference therapeutics
AMGEN PROVIDES REGULATORY UPDATE ON STATUS OF LUMAKRAS® (SOTORASIB)
Published: 2023-12-26 (Crawled : 14:00) - prnewswire.com
BGNE S | $131.94 0.06% 0.06% 130K
|
Health Technology
|
| O: 0.36%
H: 1.17%
C: -0.59%
AMGN | $262.77 -0.49% -0.49% 2M
|
Health Technology
|
| O: -0.01%
H: 0.21%
C: -0.08%
lumakras update
FDA Grants Priority Review to Amgen's Tarlatamab Application for Advanced Small Cell Lung Cancer
Published: 2023-12-13 (Crawled : 21:00) - prnewswire.com
BGNE S | $131.94 0.06% 0.06% 130K
|
Health Technology
|
| O: 0.91%
H: 2.03%
C: 1.4%
AMGN | $262.77 -0.49% -0.49% 2M
|
Health Technology
|
| O: -0.11%
H: 0.5%
C: -1.78%
fda lung review cancer cell application grants advanced
AMGEN ANNOUNCES 2024 FIRST QUARTER DIVIDEND INCREASE TO $2.25 PER SHARE
Published: 2023-12-12 (Crawled : 21:00) - prnewswire.com
BGNE S | $131.94 0.06% 0.06% 130K
|
Health Technology
|
| O: 0.25%
H: 2.68%
C: 1.83%
AMGN | $262.77 -0.49% -0.49% 2M
|
Health Technology
|
| O: 0.06%
H: 2.8%
C: 2.72%
first
AMGEN HIGHLIGHTS HEMATOLOGY PORTFOLIO AT ASH 2023
Published: 2023-12-08 (Crawled : 14:00) - prnewswire.com
BGNE S | $131.94 0.06% 0.06% 130K
|
Health Technology
|
| O: -1.32%
H: 0.78%
C: -1.13%
AMGN | $262.77 -0.49% -0.49% 2M
|
Health Technology
|
| O: -0.05%
H: 0.3%
C: -0.76%
AMGEN PRESENTS NEW CARDIOVASCULAR RESEARCH AT AHA 2023
Published: 2023-11-10 (Crawled : 14:00) - prnewswire.com
BGNE S | $131.94 0.06% 0.06% 130K
|
Health Technology
|
| O: 2.63%
H: 2.5%
C: 2.35%
AMGN | $262.77 -0.49% -0.49% 2M
|
Health Technology
|
| O: 0.98%
H: 0.49%
C: 0.25%
research cardiovascular
AMGEN PRESENTS NEW RESEARCH IN EARLY PSORIATIC ARTHRITIS AT ACR 2023
Published: 2023-11-07 (Crawled : 21:00) - prnewswire.com
BGNE S | $131.94 0.06% 0.06% 130K
|
Health Technology
|
| O: 0.66%
H: 1.5%
C: 0.61%
AMGN | $262.77 -0.49% -0.49% 2M
|
Health Technology
|
| O: 0.48%
H: 0.86%
C: 0.31%
research
AMGEN PRESENTS NEW DATA THAT SHOW BLOOD PRESSURE DECREASES FOR ADULTS TREATED WITH KRYSTEXXA® (PEGLOTICASE)
Published: 2023-11-02 (Crawled : 14:00) - biospace.com/
BGNE S | $131.94 0.06% 0.06% 130K
|
Health Technology
|
| O: 0.5%
H: 2.69%
C: -0.09%
AMGN | $262.77 -0.49% -0.49% 2M
|
Health Technology
|
| O: 0.94%
H: 1.82%
C: 1.25%
krystexxa blood show
SpringWorks Therapeutics Reports Third Quarter 2023 Financial Results and Recent Business Highlights
Published: 2023-11-02 (Crawled : 11:00) - globenewswire.com
SWTX | $42.48 -3.7% -3.84% 810K
|
Health Technology
|
| O: 4.14%
H: 6.22%
C: 1.41%
BGNE S | $131.94 0.06% 0.06% 130K
|
Health Technology
|
| O: 0.5%
H: 2.69%
C: -0.09%
AMGN | $262.77 -0.49% -0.49% 2M
|
Health Technology
|
| O: 0.94%
H: 1.82%
C: 1.25%
business therapeutics financial results
AMGEN TO PRESENT DATA AT ACR 2023 ACROSS EXPANDED RHEUMATOLOGY PIPELINE AND PORTFOLIO
Published: 2023-11-01 (Crawled : 20:00) - biospace.com/
BGNE S | $131.94 0.06% 0.06% 130K
|
Health Technology
|
| O: -1.12%
H: 1.26%
C: -1.57%
AMGN | $262.77 -0.49% -0.49% 2M
|
Health Technology
|
| O: 0.22%
H: 1.92%
C: 1.78%
pipeline
AMGEN REPORTS THIRD QUARTER FINANCIAL RESULTS
Published: 2023-10-31 (Crawled : 11:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 1.4K
|
Health Technology
|
| O: 4.66%
H: 0.0%
C: -3.51%
BMY | $48.3 0.96% -0.1% 11M
|
Health Technology
|
| O: 0.25%
H: 0.54%
C: 0.29%
XNCR | $18.98 -0.47% -0.47% 470K
|
Health Technology
|
| O: -0.41%
H: 2.1%
C: 1.11%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: 2.61%
H: 0.0%
C: 0.0%
REGN | $893.66 -0.84% -0.84% 450K
|
Health Technology
|
| O: -0.33%
H: 0.92%
C: 0.61%
BGNE S | $131.94 0.06% 0.06% 130K
|
Health Technology
|
| O: 0.14%
H: 0.68%
C: -0.32%
AMGN | $262.77 -0.49% -0.49% 2M
|
Health Technology
|
| O: -2.77%
H: 0.6%
C: -0.07%
financial results
Gainers vs Losers
| 64% | 36% |
Top 10 Gainers
AGBA | $1.02 155.0% 57.94% 120M
|
Finance
ZCMD | $2.86 108.76% 52.1% 2.3M
|
Commercial Services
INVO | $1.555 104.6% 51.13% 5M
|
Health Technology
ISPC | $0.437 105.16% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | $0.92 84.0% 45.65% 1.6M
|
OST | $0.499 21.38% 45.26% 1.9M
|
XPON | $3.1 60.62% 37.74% 17M
|
TIRX | $0.7 44.39% 30.74% 58M
|
BNTC | $6.92 44.17% 30.64% 3.5M
|
Health Technology
GGE | $0.035 19.86% 29.3% 64M
|
Your saved searches
Save your searches and get alerts when important news are released.